Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient

Cancer Immunology, Immunotherapy

Volumn 56, Issue 4, 2007, Pages 527-533

  Sørensen, Rikke Bæk ^a   Hadrup, Sine Reker ^a   Køllgaard, Tania ^a   Svane, Inge Marie ^b   Thor Straten, Per ^a   Andersen, Mads Hald ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; PROTEIN BCL X; PROTEIN BCL XL; TUMOR ANTIGEN;

ARTICLE; B LYMPHOCYTE; BLOOD; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL CLONE; COLON CANCER; CONTROLLED STUDY; CYTOLYSIS; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; BCL-X PROTEIN; BREAST NEOPLASMS; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HLA-A2 ANTIGEN; HUMANS; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33846849618     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-006-0200-4     Document Type: Article

References (15)

1. Andersen MH, Bonfill JE, Neisig A, Arsequell G, ndergaard I, Neefjes J, Zeuthen J, Elliott T, Haurum JS (1999) Phosphorylated peptides can be transported by tap molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J Immunol 163:3812
2. Andersen MH, Pedersen LO, Becker JC, thor Straten P (2001) Identification of a cytotoxic T lymphocyte response to the apoptose inhibitor protein survivin in cancer patients. Cancer Res 61:869
3. Andersen MH, Reker S, Kvistborg P, Becker JC, thor Straten P (2005) Spontaneous immunity against Bcl-X(L) in cancer patients. J Immunol 175:2709
4. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597
5. Cameron RB, Spiess PJ, Rosenberg SA (1990) Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. J Exp Med 171:249
6. Fry TJ, Mackall CL (2001) Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 22:564
7. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58:5071
8. Kirkin AF, Reichert Petersen T, Olsen AC, Li L, thor Straten P, Zeuthen J (1995) Generation of human-melanoma specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol Immunother 41:71
9. Levings MK, Sangregorio R, Roncarolo MG (2001) Human cd25( + )cd4( + ) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295
10. Nakagawara A (1998) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11:115
11. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI (2001) Human CD4( + ) CD25( + ) cells: a naturally occurring population of regulatory T cells. Blood 98:2736
12. Schmidt SM, Schag K, Muller MR, Weck MM, Appel S, Kanz L, Grunebach F, Brossart P (2003) Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells. Blood 102:571
13. Shangary S, Johnson DE (2003) Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia 17:1470
14. Wacheck V, Selzer E, Gunsberg P, Lucas T, Meyer H. Thallinger C, Monia BP, Jansen B (2003) Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells. Br J Cancer 89:1352
15. Wang S, Yang D, Lippman ME (2003) Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. Semin Oncol 30:133